Hypnosis for hot flashes among postmenopausal women study: A study protocol of an ongoing randomized clinical trial

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Elkins, Gary R ^a   Fisher, William I ^a   Johnson, Aimee K ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ANXIETY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; HYPNOSIS; MAJOR CLINICAL STUDY; PITTSBURGH SLEEP QUALITY INDEX; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; SEXUAL FUNCTION; SLEEP QUALITY; TREATMENT OUTCOME; VISUAL ANALOG SCALE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; HYDROCORTISONE; HYPNOSIS; MIDDLE AGED; POSTMENOPAUSE;

EID: 80053624565     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-92     Document Type: Article

References (39)

1. Bachmann GA. Vasomotor flushes in menopausal women. American Journal of Obstetrics and Gynecology 1999, 180:312-316.
2. Carpenter JS, Johnson DH, Wagner LJ, Andrykowski MA. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncology Nursing Forum 2002, 29:3.
3. Kronenberg F. Hot flashes: Epidemiology and physiology. Annuals of the New York Academy of Science 1990, 592:52-86.
4. Stearns V, Ulmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet 2002, 360:1851-1861. 10.1016/S0140-6736(02)11774-0, 12480376.
5. Stein KD, Jacobsen PB, Hann DH, Greenberg H, Lyman G. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management 2002, 19:436-445.
6. Kronenberg F. Hot flashes: Phenomenology, quality of life, and search for treatment options. Experimental Gerontology 1994, 29:319-336. 10.1016/0531-5565(94)90012-4, 7925752.
7. Hunter M, Liao K. A psychological analysis of menopausal hot flushes. British Journal of Clinical Psychology 1995, 34:589-599.
8. Glaus A, Boehme C, Thurliman B, Ruhstaller T, Hsu Schmitz S, Morant R, et al. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Annuals of Oncology 2006, 17:801-806.
9. Lamb M. Effects of cancer on the sexuality and fertility of women. Seminars in Oncology Nursing 1995, 11:120-127. 10.1016/S0749-2081(05)80019-1, 7604190.
10. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, Bate WW, Respond RM, Oesterling JE. Megestrol acetate for the prevention of hot flashes. New England Journal of Medicine 1994, 331:347-352. 10.1056/NEJM199408113310602, 8028614.
11. Working Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principle results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Working Group for the Women's Health Initiative Investigators.
12. Chelbowski R, McTiernan A. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer. Journal of Clinical Oncology 1999, 17:130-142.
13. Quella S, Loprinzi C, Barton J, Knost J, Sloan B, laVasseur D, Krupp K, Miller K, Novotny P. Evaluation of soy phyoestogens for treatment of hot flashes in breast cancer survivors: A north central cancer treatment group trial. Journal of Clinical Oncology 2000, 18:1068-107.
14. Barton D, Loprinzi C, Quella S, Sloan J, Veeder M, Egner J, Fidler P, Stella P, Swan D, Vaught N, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology 1998, 16:495-500.
15. Loprinzi C. 900 mg daily of gabapentin was effective for hot flashes in women with breast cancer. ACP J Club 2006, 144:41.
16. Uebelhack R, Blohmer J, Graubaum H, Busch R, Gruenwald J, Wernecke K. Black cohosh and St. John's wort for climacteric complaints: A randomized trial. Obstetrics and Gynecology 2006, 107:247-255. 10.1097/01.AOG.0000196504.49378.83, 16449108.
17. Pandya K, Raubertas R, Flynn P, Hynes H, Rosenbluth R, Kirshner J, Pierce H, Dragalin V, Morrow G. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Annals of Internal Medicine 2000, 132:788-793.
18. Goldberg R, Loprinzi C, O'Fallon J, Veeder M, Miser A, Maillard J, Michalak J, Dose A, Rowland K, Burnham N. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Journal of Clinical Oncology 1996, 12:155-158.
19. Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L. Nonhormonal therapies for menopausal hot flashes. Journal of the American Medical Association 2006, 295:2057-2071. 10.1001/jama.295.17.2057, 16670414.
20. Loprinzi C, Pisansky T, Fonseca R, Sloan J, Zahasky K, Quella S, Novotny P, Rummans T, Dumesic D, Perez E. Pilot evaluation of evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of Clinical Oncology 1998, 16:2377-2381.
21. Loprinzi C, Kugler J, Sloan J, Mailliard J, LaVasseur B, Barton D, Novotony P, Dakhill S, Rodger K, Rummans T, Christensen B. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised trial. Lancet 2000, 356:1486-1490. 10.1016/S0140-6736(00)02873-7, 11081533.
22. Stearns V, Beebe Lyengar Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. Journal of the American Medical Association 2003, 289:2827-34. 10.1001/jama.289.21.2827, 12783913.
23. Sterns V, Slack MS, Greep N, Henry-Tilman R, Osborne M, Bunnell B, Ullmer L, Gallager A, Cullen A, Gehan E, Hayes DF, Isaacs C. Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical. Journal of Clinical Oncology 2005, 23:6919-30. 10.1200/JCO.2005.10.081, 16192581.
24. Loprinzi C, Sloan J, Perez P, Quella S, Stella P, Maillard J, Halyard M, Pruthi S, Novotny P, Rummans T. Phase III evaluation of fluoxetine for treatment of hot flashes. Journal of clinical oncology 2002, 20:1578-1583. 10.1200/JCO.20.6.1578, 11896107.
25. Kimmick G, Lavato J, McQuellon R, Robinson E, Muss H. Randomized, placebo-controlled study of sertraline (Zoloft TM) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. The Breast Journal 2006, 12:114-122. 10.1111/j.1075-122X.2006.00218.x, 16509835.
26. Elkins GR, Cheung A, Marcus J, Palamara L, Rajab H. Hypnosis to reduce pain in cancer survivors with advanced disease: A prospective study. Journal of Cancer Integrative Medicine 2004, 2:167-172.
27. Elkins G, Marcus J, Stearns V, Rajab HM. Pilot evaluation of hypnosis for the treatment of hot flashes. Psycho Oncology 2007, 16:487-492. 10.1002/pon.1096, 17048223.
28. Elkins G, Marcus J, Stearns V, Perfect M, Rajab MH, Ruud C, Palamara L, Keith T. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. Journal of Clinical Oncology 2008, 26:5022-5026. 10.1200/JCO.2008.16.6389, 2652097, 18809612.
29. . Food and Drug Administration, U.S. Department of Health and Human Services Guidance for industry: Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-recommendations for clinical evaluation. The Division of Drug Information (HFD-240), Center for Drug Evaluation and Research, 5600 Fishers Lane, Rockville, M.D., 20857. 2003, Food and Drug Administration, U.S. Department of Health and Human Services., http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135338.pdf
30. National Institute of Health Assessing and improving measures of hot flashes. 2004, Last accessed September 29 2011, National Institute of Health., http://nccam.nih.gov/health/hotflashes/
31. North American Menopause Society Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004, 11:11-33. 10.1097/01.GME.0000108177.85442.71, 14716179, North American Menopause Society.
32. Elkins GR, Handel DL. Clinical hypnosis: An essential in the tool kit for family practice. Behavioral Medicine in Family Practice: Clinics in Family Practice 2001, 3:113-126.
33. Jensen M, Patterson D. Control conditions in hypnotic-analgesia clinical trials: challenges and recommendations. The international journal of clinical and experimental hypnosis 2005, 53:170-197. 10.1080/00207140590927536, 16028332.
34. Lang E, Benotsch E, Fick L, Lutgendorf S, Berbaum M, Berbaum K, Logan H, Spiegel D. Adjunctive non-pharmacological analgesia for invasive medical procedures: A randomized trial. Lancet 2000, 355:1486-1490. 10.1016/S0140-6736(00)02162-0, 10801169.
35. UFI, (2011, July 27). Model 3991 SCL; UFI, Morro Bay, CA [product site]., http://www.UFIservingscience.com/biologs.html
36. Lykken D, Venables P. Direct measurement of skin conductance: A proposal for standardization. Psychophysiology 1971, 8:656-672. 10.1111/j.1469-8986.1971.tb00501.x, 5116830.
37. Dormire S, Carpenter J. An alternative to unibase/glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity. Psychophysiology 2002, 39:423-426. 10.1111/1469-8986.3940423, 12212634.
38. Webster J, Bahr D, Shults M, Grady D, Macer J. A miniature sternal skin-attached hot flash recorded. IFMBE Proceedings 2007, 14:676-679.
39. Pruessner J, Kirschbaum C, Meinlschmidt C, Hellhammer D. Two formulas for the computation for the area under the curve represent total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931. 10.1016/S0306-4530(02)00108-7, 12892658.